Publication Technique Important changes Sample type Amount (n=)
Delbridge et al. MRS Lipids 1.7 ppm and 0.9 ppm amino acids regions ratio Tissue 98
King et al. MRS Choline/Creatine ratio and FA Tissue 13
Mackinnon et al. 2D 1H MRS cholesterol/cholesteryl esters and di-/triglycerides Tissue 93
Gupta et al. MRS Choline Tissue 8
Jordan et al. 1HRMAS Lipids 1.7 ppm and 0.9 ppm amino acids regions ratio Tissue 13
Toregrrossa et al. 1HRMAS Lactate, taurine, choline, phosphocholine, myo-inositol, scylloinositol and unknown compounds Tissue 72
Yoshioka et al. 1H NMR Dolichols, cholesterol, acyl chain double bounds, PC+SPH Tissue 61
Raffelt et al 31P NMR PR+SM and PC Plasma 70
Deja et al. 1H NMR Alanine, methionine, acetone, glutamate, glycine, lactate, tyrosine, phenylalanine, hypoxanthine, scyllo- and myo-inositol Tissue 64
S Guo et al FT-ICR-MS PC(34:1), PC(36:1), PC(38:6), PA(36:2), PA(36:3), PA(38:3), PA(38:4), PA(38:5), PA(40:5) and SM(34:1) Tissue/serum 36/289
Ishikawa et al. IMS, MS/MS PC (16:0/18:1 and 16:0/18:2) and SPH (d18:0/16:1 ) Tissue 7
Yao et al LC-MS FFA and 3-hydroxybutyric acid Serum 140
L Guo et al. GC-MS Ethyl hexanol, phenol, 4-hydroxybutanoic acid Exhaled breath 96
Table 1: Summary of results of metabolomic studies of changes in the thyroid gland [27,28,34-39,41,43,44,47,53].